The Cornell Board of Trustees today voted to appoint Michael I. Kotlikoff, who has served as interim president since July 2024, Cornell’s 15th president, effective immediately.

“Over the last eight months as interim president – and his 25 years on Cornell’s faculty – Mike has demonstrated the leadership and vision that the university needs right now,” said Board of Trustees Chair Kraig Kayser, MBA ’84. “His institutional knowledge, expertise and passion for our shared mission will continue to help him lead Cornell through a period of great uncertainty and provide much-needed continuity at a critical time.”

As interim president, Kotlikoff has sought to foster connection and dialogue on campus and to highlight the unique attributes of Cornell – including its history and its ethos. 

“I’ve spent 25 wonderful years at Cornell, and serving this university is an honor and a privilege,” Kotlikoff said. “I’m committed to finishing my career here, leading an institution I love through these challenging times. As higher education across the U.S. navigates difficult political, financial and societal headwinds, I hope to guide Cornell in ways that reflect our core principles as an institution committed to doing ‘the greatest good.’” 

A professor of molecular physiology, Kotlikoff arrived at Cornell in 2000 to build a new department in biomedical sciences at the College of Veterinary Medicine (CVM). He also launched and led the university’s Mammalian Genomics Life Science Initiative. He was named dean of CVM in 2007, and he became university provost in 2015. 

“Mike has been a dedicated advocate and champion for Cornell for decades,” said Anne Meinig Smalling ’87, chair of the Board of Trustees Executive Committee and the incoming board chair. “His values, knowledge and insights are deeply appreciated by all who know him. I and the other trustees look forward to working with Mike in the months and years ahead.”

Previously, Kotlikoff was professor and chair of the Department of Animal Biology at the University of Pennsylvania, where he earned his B.A. in 1973 and VMD in 1981, with a Ph.D. from the University of California, Davis, in 1984. 

By the time he was hired at Cornell in 2000, his research interests had expanded from studying ion channel proteins that control muscle excitability to using genetics to understand the fundamental processes that underlie and limit repair of the damaged mammalian heart. His arrival opened new opportunities for studying mouse genetics at the university. His lab’s breakthroughs included developing optogenetic signaling molecules that can be expressed in mice to explore cell function; ways to use cell therapy to treat cardiac arrythmias in injured hearts; and an understanding of the limits of precursor cells in heart repair. He has published 152 papers and his lab, which he closed in 2021, was continuously funded by the National Institutes of Health since he began his research career. He has served in numerous roles at the NIH, including chairing the Board of Scientific Counselors at the National Heart, Lung, and Blood Institute and serving on the NIH Council of Councils. 

Kotlikoff also has the distinction of having been Cornell’s longest-serving provost and served as chief budget officer in addition to chief academic officer. As provost, he helped steward many large and complicated projects, such as the creation of the SC Johnson College of Business and the Cornell Jeb E. Brooks School of Public Policy; the Radical Collaboration initiative; the North Campus Residential Expansion; and the university’s COVID-19 response.

His wife, Carolyn McDaniel, retired in 2024 as a professor of practice in CVM. They have two children: Phoebe, a lawyer and former submarine officer with the U.S. Navy, and Emmett ’16, who graduated from Cornell with a bachelor’s degree in computer science and currently works for Google.